GHS Classification Guidance for the Japanese Government

GHS Classification Guidance for the Japanese Government GHS Classification Guidance for the Japanese Government

04.06.2013 Views

* Unless a description that definitely denies hazards or recognizes extremely low hazards is available in List 1, the determination of “Not classified” should be performed carefully. If there is any question, a given substance should rather be classified in “Classification not possible” due to insufficient information for judgment. * When an affected organ can be identified, indicate the applicable category along with the affected organ in parentheses forGHS classification.” When such an organ cannot be identified, put “systemic toxicity” in parentheses. (Example entry:Category 1 (liver, kidney, blood), or Category 1 (systemic toxicity)) * In a case where a substance can be classified in Category 1 (respiratory organs) or Category 2 (respiratory organs), it shall be not classified in Category 3 (respiratory tract irritation). * When the same substance is classified into different categories depending on affected organs, indicate the category for each of the affected organs. (Example entry: Category 1 (liver, kidney), Category 2 (blood), Category 3 (respiratory tract irritation)) * As for substances of which data are available only for a mixture (provided mixed or diluted with solvents without toxicity), their GHS classification as pure substances are performed by estimating from concentrations appropriately, and the estimation processes are to be described as a ground for classification. B) Regarding classification procedure 1) Substances meeting [Decision criteria 1a] or [Decision criteria 1b] below are placed in Category 1. [Decision criteria 1a]: Substances for which evidence of inducing toxic effects in humans are (Notes) available in List 1. a) Effects on organs that are obviously known to be secondary effects shall be excluded from description. Judgement by experts shall be sought for where necessary about whether the effects are secondary or not. When such a judgment is difficult, all organs affected shall be cited. b) Effects on respiratory system by site of contact are included here, and are placed in Category 1 (pneumoconiosis, etc.). However, such effects by site of contact other than respiratory tract, for example, irritation/inflammation reaction in digestive system in a case of oral administration of a corrosive/irritant, are considered to be subsumed under other toxicity items such as skin corrosion, and are not classified in specific target organ toxicity. c) When only minimal symptoms (slight fever, languor, etc.) are reported, the substance is placed in “Not classified”. 176

d) All organs described as affected in List 1 shall be indicated. However, when organs listed in multiple assessment documents based on the same type of tests are not the same, indicate the commonly listed organs. When a toxic symptom alone is described and the affected organ cannot be identified, put “systemic toxicity” instead. When the target organ is identified, fundamentally, a description of toxic symptom is not required. e) When the affected organ can be identified, indicate the applicable category along with the affected organ in parentheses in “GHS classification”. When the affected organ cannot be identified, put “systemic toxicity” in parentheses. [Decision criteria 1b]: Animal tests meeting all of conditions below a) Any animal species is applicable. b) Exposure amount is identified and toxic symptom is induced within the guidance value range of Category 1 c) The test is described in List 1 or an OECD TG test in List 2, is according to GLP, and has received some degree of approval (by multiple reviewers) (Notes) a) As for toxic effects, read the UN GHS second revised edition and the following documents carefully. b) Effects on organs that are obviously known to be secondary effects shall be excluded from description. Judgement by experts shall be sought for where necessary as to whether the effects are secondary or not. c) Effects on respiratory system by site of contact are included here and are placed in Category 1 (pneumoconiosis, etc.). However, such effects by site of contact other than respiratory tract, for example, irritation/inflammation reaction in digestive system in a case of oral administration of a corrosive/irritant, are considered to be subsumed under other toxicity items such as skin corrosion and are not classified in specific target organ toxicity. d) When only minimal symptoms (slight fever, etc.) are reported, the substance is placed in “Not classified”. e) All organs described as affected in List 1 shall be indicated. However, when organs listed in multiple assessment documents based on the same type of tests are not the same, indicate the commonly listed organs. When a toxic symptom alone is described and the affected organ cannot be identified, put “systemic toxicity” instead. When the target organ is identified, fundamentally, a description of toxic symptom is not required. f) As for conversion of exposure amount, the technical guideline for acute toxicity shall be used (except for the criteria for dealing with animal species difference). 177

d) All organs described as affected in List 1 shall be indicated. However, when organs<br />

listed in multiple assessment documents based on <strong>the</strong> same type of tests are not <strong>the</strong><br />

same, indicate <strong>the</strong> commonly listed organs. When a toxic symptom alone is described<br />

and <strong>the</strong> affected organ cannot be identified, put “systemic toxicity” instead. When <strong>the</strong><br />

target organ is identified, fundamentally, a description of toxic symptom is not required.<br />

e) When <strong>the</strong> affected organ can be identified, indicate <strong>the</strong> applicable category along with<br />

<strong>the</strong> affected organ in paren<strong>the</strong>ses in “<strong>GHS</strong> classification”. When <strong>the</strong> affected organ<br />

cannot be identified, put “systemic toxicity” in paren<strong>the</strong>ses.<br />

[Decision criteria 1b]: Animal tests meeting all of conditions below<br />

a) Any animal species is applicable.<br />

b) Exposure amount is identified and toxic symptom is induced within <strong>the</strong> guidance value<br />

range of Category 1<br />

c) The test is described in List 1 or an OECD TG test in List 2, is according to GLP, and<br />

has received some degree of approval (by multiple reviewers)<br />

(Notes)<br />

a) As <strong>for</strong> toxic effects, read <strong>the</strong> UN <strong>GHS</strong> second revised edition and <strong>the</strong> following<br />

documents carefully.<br />

b) Effects on organs that are obviously known to be secondary effects shall be excluded<br />

from description. Judgement by experts shall be sought <strong>for</strong> where necessary as to<br />

whe<strong>the</strong>r <strong>the</strong> effects are secondary or not.<br />

c) Effects on respiratory system by site of contact are included here and are placed in<br />

Category 1 (pneumoconiosis, etc.). However, such effects by site of contact o<strong>the</strong>r than<br />

respiratory tract, <strong>for</strong> example, irritation/inflammation reaction in digestive system in a<br />

case of oral administration of a corrosive/irritant, are considered to be subsumed under<br />

o<strong>the</strong>r toxicity items such as skin corrosion and are not classified in specific target organ<br />

toxicity.<br />

d) When only minimal symptoms (slight fever, etc.) are reported, <strong>the</strong> substance is placed<br />

in “Not classified”.<br />

e) All organs described as affected in List 1 shall be indicated. However, when organs<br />

listed in multiple assessment documents based on <strong>the</strong> same type of tests are not <strong>the</strong><br />

same, indicate <strong>the</strong> commonly listed organs. When a toxic symptom alone is described<br />

and <strong>the</strong> affected organ cannot be identified, put “systemic toxicity” instead. When <strong>the</strong><br />

target organ is identified, fundamentally, a description of toxic symptom is not required.<br />

f) As <strong>for</strong> conversion of exposure amount, <strong>the</strong> technical guideline <strong>for</strong> acute toxicity shall be<br />

used (except <strong>for</strong> <strong>the</strong> criteria <strong>for</strong> dealing with animal species difference).<br />

177

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!